These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 38036859

  • 1. Elevated plasma myoglobin level is closely associated with type 2 diabetic kidney disease.
    Yang L, Shen Y, Li W, Zha B, Xu W, Ding H.
    J Diabetes; 2024 Mar; 16(3):e13508. PubMed ID: 38036859
    [Abstract] [Full Text] [Related]

  • 2. Association between hemoglobin glycation index and diabetic kidney disease in type 2 diabetes mellitus in China: A cross- sectional inpatient study.
    Xin S, Zhao X, Ding J, Zhang X.
    Front Endocrinol (Lausanne); 2023 Mar; 14():1108061. PubMed ID: 36967789
    [Abstract] [Full Text] [Related]

  • 3. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR, Sharma K.
    Am J Nephrol; 2018 Mar; 47(5):283-291. PubMed ID: 29779026
    [Abstract] [Full Text] [Related]

  • 4. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018.
    Guo W, Song Y, Sun Y, Du H, Cai Y, You Q, Fu H, Shao L.
    Front Endocrinol (Lausanne); 2022 Mar; 13():1071465. PubMed ID: 36561561
    [Abstract] [Full Text] [Related]

  • 5. Fibrinogen to Albumin Ratio as an Independent Risk Factor for Type 2 Diabetic Kidney Disease.
    Wang K, Xu W, Zha B, Shi J, Wu G, Ding H.
    Diabetes Metab Syndr Obes; 2021 Mar; 14():4557-4567. PubMed ID: 34815682
    [Abstract] [Full Text] [Related]

  • 6. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M, Zhao B, Xie J, Liang Y, Yang Z.
    Biomed Res Int; 2019 Mar; 2019():4831459. PubMed ID: 31815140
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
    Xu X, Dong Y, Liu M, Li Y, Zhang Y.
    Nefrologia (Engl Ed); 2021 Mar; 41(5):548-555. PubMed ID: 36165137
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S, Chen J, Wu L, Nie G, Sun L, Zhang C, Huang Z, Xing C, Zhang B, Yuan Y.
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [Abstract] [Full Text] [Related]

  • 13. [Blood Lipid Indicators and Different Clinical Classifications of Dyslipidemia and Diabetic Kidney Disease: Correlation and Predictive Value].
    Hu Y, Du X.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):1013-1018. PubMed ID: 37866961
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J, Wang B, Shen FJ, Zhang TT, Duan Z, Zhou DM.
    BMC Nephrol; 2022 Jul 27; 23(1):270. PubMed ID: 35896961
    [Abstract] [Full Text] [Related]

  • 15. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N, Russell J, El Nahas M.
    Nephrol Dial Transplant; 2012 May 27; 27(5):1847-54. PubMed ID: 22058177
    [Abstract] [Full Text] [Related]

  • 16. Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.
    Liu T, Zhao H, Wang Y, Qu P, Wang Y, Wu X, Zhao T, Yang L, Mao H, Peng L, Zhan Y, Li P.
    Front Immunol; 2024 May 27; 15():1334109. PubMed ID: 38481996
    [Abstract] [Full Text] [Related]

  • 17. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S, Sun L, Nie G, Chen J, Zhang C, Zhu H, Huang Z, Qian J, Zhao X, Xing C, Zhang B, Yuan Y.
    Front Immunol; 2020 May 27; 11():2073. PubMed ID: 32983156
    [Abstract] [Full Text] [Related]

  • 18. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study.
    Li X, Wang L, Liu M, Zhou H, Xu H.
    Front Endocrinol (Lausanne); 2023 May 27; 14():1285509. PubMed ID: 38239986
    [Abstract] [Full Text] [Related]

  • 19. Implications of increased circulating macrophage inhibitory protein-5 in patients with type 2 diabetes mellitus.
    Zhao B, Zhang M, Xie J, Jiang T, Li J, Yang Z.
    Int Immunopharmacol; 2022 Aug 27; 109():108916. PubMed ID: 35679662
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of non-diabetic kidney disease and inability of clinical predictors to differentiate it from diabetic kidney disease: results from a prospectively performed renal biopsy study.
    Basu M, Pulai S, Neogi S, Banerjee M, Bhattacharyya NP, Sengupta S, Mukhopadhyay P, Ray Chaudhury A, Ghosh S.
    BMJ Open Diabetes Res Care; 2022 Dec 27; 10(6):. PubMed ID: 36517108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.